Neumora Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Neumora Therapeutics has a total shareholder equity of $320.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $352.5M and $31.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$341.31m |
| Equity | US$320.74m |
| Total liabilities | US$31.80m |
| Total assets | US$352.54m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: NMRA's short term assets ($348.6M) exceed its short term liabilities ($31.7M).
Long Term Liabilities: NMRA's short term assets ($348.6M) exceed its long term liabilities ($55.0K).
Debt to Equity History and Analysis
Debt Level: NMRA is debt free.
Reducing Debt: NMRA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NMRA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NMRA has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 35.5% each year.